Browsing Journal/Magazine Articles by Author "Cereser, B."

Now showing items 1-9 of 9

Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy

Carter, P.; Alifrangis, C.; Cereser, B.; Chandrasinghe, P.; Del Bel Belluz, L.; Fotopoulou, C.; Frilling, A.; Herzog, T.; Moderau, N.; Tabassum, N.; Krell, J.; Stebbing, J. (Impact Journals, 2017)

Tumor molecular profiling has enabled selection of targeted therapies in a host of solid tumors. Here we used a retrospective clinical cohort, to evaluate the benefit of tailoring treatments for female genital tract ...
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas

Carter, P.; Alifrangis, C.; Chandrasinghe, P.; Cereser, B.; Del Bel Belluz, L.; Leo, C.A.; Moderau, N.; Tabassum, N.; Warusavitarne, J.; Krell, J.; Stebbing, J. (Impact Journals, 2018)
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy

Carter, P.; Alifrangis, C.; Cereser, B.; Chandrasinghe, P.; Del Bell Belliz, Z.; Fotopoulou, C.; Frilling, A.; Herzog, T.; Moderau, N.; Tabassum, N.; Krell, J.; Stebbing, J. (Impact Journals, 2018)

[This corrects the article DOI: 10.18632/oncotarget.23675.]. Erratum for : Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy. [Oncotarget. 2017; 9(5):6007-6014]
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?

Carter, P.; Alifrangis, C.; Cereser, B.; Chandrasinghe, P.; Del Bel Belluz, L.; Herzog, T.; Levitan, J.; Moderau, N.; Schwartzberg, L.; Tabassum, N.; Wen, J.; Krell, J.; Stebbing, J. (Impact Journals LLC, 2018)

This corrects the article DOI: 10.18632/oncotarget.24258.]. Erratum for Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients? [Oncotarget. 2018 ...
Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas

Carter, P.; Alifrangis, C.; Chandrasinghe, P.; Cereser, B.; Del Bel Belluz, L.; Leo, C.A.; Moderau, N.; Tabassum, N.; Warusavitarne, J.; Krell, J.; Stebbing, J. (Impact Journals LLC, 2018)

This corrects the article DOI: 10.18632/oncotarget.24257. Erratum for The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas [Oncotarget. 2018 ;9(13):11371-11376]
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?

Carter, P.; Alifrangis, C.; Cereser, B.; Chandrasinghe, P.; Del Bel Belluz, L.; Herzog, T.; Levitan, J.; Moderau, N.; Schwartzberg, L.; Tabassum, N.; Wen, J.; Krell, J.; Stebbing, J. (Impact Journals, 2018)

We evaluated the effect of tailoring treatments based on predictions informed by tumor molecular profiles across a range of cancers, using data from Caris Life Sciences. These included breast carcinoma, colorectal ...
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments

Alifrangis, C.; Carter, P.; Cereser, B.; Chandrasinghe, P.; Belluz, L.D.B.; Lim, E.; Moderau, N.; Poyia, F.; Tabassum, N.; Zhang, H.; Krell, J.; Stebbing, J. (Impact Journals, 2018)

In this study we utilized data on patient responses to guided treatments, and we evaluated their benefit for a non-small cell lung cancer cohort. The recommended therapies used were predicted using tumor molecular profiles ...
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans

Carter, P.; Alifrangis, C.; Cereser, B.; Chandrasinghe, P.; Del Bel Belluz, L.; Moderau, N.; Poyia, F.; Schwatzberg, L.S.; Tabassum, N.; Wen, J.; Krell, J.; Stebbing, J. (Impact Journals, 2018)

We used data obtained by Caris Life Sciences, to evaluate the benefits of tailoring treatments for a breast carcinoma cohort by using tumor molecular profiles to inform decisions. Data for 92 breast cancer patients from ...
Role of SMAD proteins in colitis-associated cancer: from known to the unknown

Chandrasinghe, P.; Cereser, B.; Moorghen, M.; Al Bakir, I.; Tabassum, N.; Hart, A.; Stebbing, J.; Warusavitarne, J. (MacMillan Press, 2018)

Small mothers against decapentaplegic (SMAD) proteins are a family of signal transduction molecules in transforming growth factor β (TGFβ) ligand pathways that have been found to have a key role in the pathogenesis of ...

Browsing Journal/Magazine Articles by Author "Cereser, B."

Browsing Journal/Magazine Articles by Author "Cereser, B."

Search Digital Repository

Browse

All of DSpace

This Collection

My Account